Get Started

AIM

AMEX AIM ImmunoTech Inc.
Nov 9, 2026 · 5:17 AM ET LAST TRADE Market Closed

$0.1599 ↑ +0.0049 (+3.16%) Trading Up from the previous close of $0.1550

YTD change
-85.85%
vs 20-day SMA
-2.03%
vs 200-day SMA
-65.43%

Price ranges

Previous day
$0.1476 $0.1598
open $0.1520 close $0.1550
+$0.0030 (+1.97%)
Today
$0.0000 $0.0000
$0.1599
Past week
$0.1476 $0.1725
from $0.1545 now $0.1599
+$0.0054 (+3.50%)
Past month
$0.1476 $0.1815
from $0.1800 now $0.1599
-$0.0201 (-11.17%)
This year
$0.1476 $1.8799
from $1.1300 now $0.1599
-$0.9701 (-85.85%)

Price & Performance

-0.15 (-49.63%) / 6M

$0.0924$0.3810$0.6697$0.9583May 11Aug 10Nov 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.2% away from all-time highs of $20.3500
  • AIM is down 86% since the beginning of the year
  • AIM is down 90% over the past 12 months
  • AIM is down 11% over the past 1 month
  • 4% of all AIM investors are betting against AIM
  • Number of investors short AIM has gone down 23% versus last month

AIM reads not so good: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -90.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.43
Earnings momentum -218.5% Quarterly EPS growth
Quarterly change -218.5%

Valuation

P/E ratio N/A
Enterprise value $-3439250.0
Beta 1.74

Balance sheet & scale

IncomeN/A
Revenue$95.0K
Cash$10.0M
Debt$3.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeAMEX
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $6.4M

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,354.00 -0.79%
JNJ Johnson & Johnson $276.22 +1.43%
ABBV AbbVie, Inc. $291.31 +1.07%
MRK Merck & Co., Inc. $146.73 -0.14%
RHHBY Roche Holding Ltd Sponsored ADR $59.37 -0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.